Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of large B-cells. When it occurs in the intrapelvic lymph nodes, it may present with abdominal pain, swelling, or systemic symptoms such as fever and weight loss. Accurate coding with ICD-10 Code C83.36 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources are allocated effectively.
ICD-10 Code C83.36 specifically identifies diffuse large B-cell lymphoma located in the intrapelvic lymph nodes. This aggressive lymphoma can lead to significant morbidity if not diagnosed and treated promptly. The code should be used in clinical documentation and billing when a patient presents with symptoms indicative of DLBCL affecting the pelvic region, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Diffuse large B-cell lymphoma in the intrapelvic lymph nodes is a hematological malignancy that arises from B-lymphocytes. It is characterized by aggressive growth and can lead to significant complications if left untreated. Early recognition and intervention are crucial for improving patient outcomes.
ICD-10 Code C83.36 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to diffuse large B-cell lymphoma in the intrapelvic lymph nodes. This code is relevant in both acute and chronic care settings, facilitating comprehensive patient management.
In SOAP notes, ICD-10 Code C83.36 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diffuse large B-cell lymphoma in the intrapelvic lymph nodes. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Prompt treatment of diffuse large B-cell lymphoma in the intrapelvic lymph nodes is critical due to its aggressive nature. Hospitalization may be required for intensive therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.36 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique, single or initial substance. |
| 96415 | Chemotherapy administration, intravenous, each additional substance. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C83.36 for Diffuse large B-cell lymphoma, intrapelvic lymph nodes
What are the common symptoms of diffuse large B-cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, unexplained weight loss, and fatigue. Patients may also experience abdominal pain if lymph nodes in the pelvic region are affected.
How is diffuse large B-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies (like CT scans), and biopsy of affected lymph nodes to confirm the presence of malignant B-cells.
What treatments are available for diffuse large B-cell lymphoma?
Treatment often includes chemotherapy regimens such as R-CHOP, radiation therapy, and in some cases, stem cell transplantation, depending on the stage and patient health.
Is diffuse large B-cell lymphoma curable?
Many patients can achieve remission with appropriate treatment, but outcomes vary based on factors such as stage at diagnosis and overall health. Regular follow-up is essential.
Clinical Notes
SOAP notes
DAP notes
AI medical notes